ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 705870 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 705870; 2) Community: the network communities that were significantly associated with the response to NSC 705870; 3) Molecule: the relationships between components within communities and NSC 705870; 4) MDR: the compounds that were significantly associated with the NSC 705870.

NSC Compound Enrichment Correlation
NSC 300289 Pinafide 0.0297837393005856 0.31828888
NSC 303861 L-Cysteine analog 0.0297837393005856 0.35442138
NSC 339137 PHYSALOLACTONE 0.0297837393005856 0.20075406
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.0297837393005856 0.39074457
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.0297837393005856 0.25273427
NSC 354974 Acetamide, N-(5,6,7,9-tetrahydro-2,3-dihydroxy-1,10-dimethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)- 0.0297837393005856 -0.081885224
NSC 359239 Antibiotic X-14766A 0.0297837393005856 -0.0097734778
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.0297837393005856 0.28234919
NSC 372155 2-Propenamide, N-[(cyanoamino)iminomethyl]-2-methyl- 0.0297837393005856 0.1347376
NSC 42972 Null 0.0297837393005856 0.12653873
Total:83  Current:52    [First] [Prev] [Next] [Last]